Astrana Health financials
$35.45+0.91%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $972.5M | $965.1M | $950.5M | $956.0M | $654.8M | $620.4M | $665.2M | $478.7M | $486.3M | $404.4M |
| Gross profit | $104.0M | $105.7M | $95.0M | $97.2M | $78.0M | $71.3M | $50.5M | $73.5M | $73.5M | $74.0M |
| Gross margin | 10.7% | 11.0% | 10.0% | 10.2% | 11.9% | 11.5% | 7.6% | 15.4% | 15.1% | 18.3% |
| Operating income | $34.3M | $28.5M | $18.4M | $19.2M | $20.3M | $20.6M | $720.0K | $28.4M | $30.1M | $30.1M |
| Net income | $19.7M | $14.4M | $6.0M | $373.0K | $9.4M | $6.7M | -$7.0M | $16.1M | $19.2M | $14.8M |
| Net margin | 2.0% | 1.5% | 0.6% | 0.0% | 1.4% | 1.1% | −1.0% | 3.4% | 3.9% | 3.7% |
| Diluted EPS | $0.40 | $0.29 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.33 | $0.40 | $0.31 |
| EBITDA | $49.9M | $44.0M | $34.8M | $34.8M | $27.2M | $27.4M | $8.8M | $35.7M | $37.5M | $35.2M |
| Operating cash flow | $32.7M | $68.1M | -$2.9M | $10.0M | $90.9M | $16.6M | -$10.9M | $34.0M | $23.2M | $6.0M |
| Free cash flow | $28.9M | $64.1M | -$6.0M | $7.4M | $89.5M | $13.6M | -$13.5M | $31.7M | $20.4M | $5.6M |
| Diluted shares | 49.8M | 49.1M | 49.7M | 49.5M | 49.5M | 48.9M | 48.0M | 48.2M | 48.0M | 47.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $400.8M | $478.4M | $429.5M | $462.2M | $339.7M | $258.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $1.2M | $2.4M | $2.4M |
| Total debt | $936.5M | $1.03B | $1.04B | $1.05B | $413.6M | $417.4M |
| Total assets | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B |
| Total liabilities | $1.68B | $1.78B | $1.66B | $1.68B | $904.4M | $813.5M |
| Shareholders' equity | $840.8M | $815.2M | $793.3M | $789.1M | $771.5M | $750.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology